Nkarta Announces Three NKX019 Presentations At ACR Convergence 2026 On November 6-11, Including Two Oral Presentations On Ntrust Phase 1/2 Safety And Idiopathic Inflammatory Myopathy Activity

Loading news article.

Nkarta Announces Three NKX019 Presentations At ACR Convergence 2026 On November 6-11, Including Two Oral Presentations On Ntrust Phase 1/2 Safety And Idiopathic Inflammatory Myopathy Activity | WAPE

Nkarta Announces Three NKX019 Presentations At ACR Convergence 2026 On November 6-11, Including Two Oral Presentations On Ntrust Phase 1/2 Safety And Idiopathic Inflammatory Myopathy Activity

Article summary

Related companies

Comments —